Spring direct naar de hoofdnavigatie of de inhoud

SME

Home / Our clients / SME

SME

SME

Midsized companies are a driving force for innovation. In fact, some of the greatest inventions were made by midcorporates. However, often the expertise to protect these inventions is not available in-house. This is where we come in. With our hands-on knowledge and experience, you are able to obtain protection for your inventions and make them a valuable asset for your company.

Great number of midcorporate clients

Amongst our clients are a great number of midcorporates. We handle any of the IP issues that you may encounter. For example, we draft your patent applications, defend your patents or assert your patents against 3rd parties that may be using your inventions. We help you to build up a balanced portfolio and manage it successfully, so that the value of your Intellectual Property is maximized.

All relevant expertise for your business

With more than 60 attorneys we cover a broad field of specialisms and sectors. This ensures that you will work with an attorney that has knowledge and experience that is relevant to your business. Our offices are located in regions that are centres of innovation throughout the Netherlands, Belgium and Germany, so we’re always close to you. With a well developed network of patent agencies worldwide, we can ensure the best form of protection worldwide.

Dedicated team

A dedicated team of patent attorneys is at your disposal to provide the services that are needed by companies like yours. With this team, we always strive to find new ways to maximize the value of your innovations and achieve a balance between costs and potential revenues.

Contact our experts

Peter de Lange

  • European Patent Attorney
  • Dutch Patent Attorney
  • Associate
More experts

News

The consequences of the Nagoya Protocol

  The Nagoya Protocol is highly relevant for the Dutch seed culture sector. But the content of the protocol is far from easy to understand. IP Leads summarises the main provisions for you and the most important consequences.Continue reading

No happy ending for a pharmaceutical company in a case involving a Native American tribe

In the case known as Mohawk tribe versus Mylan, the US Federal Circuit Court of Appeals ruled that patent holders cannot shield themselves from an “inter partes review” of a patent by assigning that patent to a Native American tribe. Ironically enough, this is due to the fact that the decision handed down by the […]Continue reading

Does the new law for the protection of trade secrets offer sufficient protection?

On 9 June, the new law for the protection of trade secrets came into force (based on European Directive 2016/943/EU). On the basis of the law, it is possible to take action against the illegal acquisition, use and disclosure of trade secrets. If a trade secret is misused, the holder can bring various actions based […]Continue reading

Events

European Biotech and Pharma Partnering Conference 2018

Osaka, Japan,Congres Convention Centre Second Basement, North Building, Grand Front Osaka

The European Biotech and Pharma Partnering Conference in Osaka offers business contacts to industry professionals who are looking for potential partners in the EU and Japan to ensure sustainable business development and growth. More about this event

BIO JAPAN 2018 – Flemish Life Sciences & Biotech Week

Pacifico Yokohama, 1 Chome-1 Minatomirai, Nishi Ward, Yokohama, Kanagawa, Japan

Asia's Premier Partnering Event for the Global Biotechnology Industry BioJapan has played an important role in facilitating interaction between Japanese and global companies/organizations and stimulating new business opportunities for almost two decades. More about this event

The London IP Summit 2018

Four Seasons Hotel London at Park Lane, Hamilton Place, Park Lane, London, Verenigd Koninkrijk

The London IP Summit is an industry leading event dedicated to bringing together IP owners, experts and investors to address key challenges and operational issues faced by companies and IP professionals today. More about this event